Anika Therapeutics | ANIK - Trade Creditors


Anika Therapeutics reported $6.34M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Abbott USD 4.24B 117M Dec/2025
Agenus USD 82.99M 2.3M Dec/2025
Agios Pharmaceuticals USD 13.75M 4.61M Mar/2026
Anika Therapeutics USD 6.34M 298K Mar/2026
Arrowhead Research USD 32.94M 15.26M Dec/2025
Enanta Pharmaceuticals USD 1.88M 63K Dec/2025
Halozyme Therapeutics USD 20.9M 5.54M Dec/2025
Heron Therapeutics USD 8.99M 3.02M Dec/2025
Insmed USD 79.91M 316K Dec/2025
Integra LifeSciences USD 95.73M 3.42M Dec/2025
Intrexon USD 4.85M 3.12M Jun/2024
J&J USD 10.46B 1.53B Mar/2026
Karyopharm Therapeutics USD 4M 1.39M Dec/2025
Ligand Pharmaceuticals USD 3.24M 24.52M Dec/2025
MacroGenics USD 4.79M 1.15M Dec/2025
Merit Medical Systems USD 67.85M 7.3M Mar/2026
Rigel Pharmaceuticals USD 3.85M 3.44M Sep/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sanofi EUR 22.71B 219M Mar/2026
Smith & Nephew USD 1.19B 73M Dec/2025
Stryker USD 1.8B 301M Dec/2025
Surmodics USD 5.93M 3.14M Jun/2025
Veracyte USD 4.59M 916K Dec/2025
Xencor USD 10.83M 1.75M Dec/2025
Zimmer Biomet Holdings USD 361.2M 58.2M Mar/2026